Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-01

Clinical Trial Update: A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Nurtec ODT (rimegepant) to Maxalt MLT-ODT (rizatriptan) in adults presenting to the emergency department with migraine. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maxalt MLT-ODT (rizatriptan)
  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Antonios Likourezos | Conditions: Migraine | Phase 4 | Status: RECRUITING